Breakthrough Dengue Cure Found, but Industry Hurdle Blocks Access
Multi-Source Journalism
This article synthesizes reporting from multiple credible news sources to provide comprehensive, balanced coverage.
Multi-Source Journalism
This article synthesizes reporting from multiple credible news sources to provide comprehensive, balanced coverage.
Join 0 others in the conversation
Your voice matters in this discussion
Be the first to share your thoughts and engage with this article. Your perspective matters!
Discover more articles
Researchers have successfully developed a cure for dengue, a mosquito-borne disease that affects over 14 million people annually, by creating a pill called mosnodenvir that can stop the virus from replicating. However, the major obstacle to widesprea
A recent deal between the US government and Pfizer, aimed at reducing prescription drug prices, may not be effective in addressing the issue, according to a new analysis. The agreement, part of the most-favoured nation scheme, has been criticized for
The US is accelerating the rollout of a groundbreaking HIV prevention drug, lenacapavir, which can be administered just twice a year, but has excluded South Africa from its initial distribution, despite being a country with one of the highest HIV pre
A groundbreaking correction has been made to a 2016 study on antimalarial inhibitors, ensuring the accuracy of crucial research data. The correction involves replacing a duplicate image with the correct one in Extended Data Fig. 3c, a move that will
For the first time in human history, the tools exist to prevent the next pandemic, but global inaction threatens to undo decades of scientific progress. Despite advances in detection, treatment, and prevention, the likelihood of another widespread ou
Goats and Soda A 'breakthrough' drug to prevent HIV, an 'unprecedented' rollout November 18, 20258:31 AM ET By Jonathan Lambert A pharmacist holds a vial of lenacapavir, described as a "breakthrough" HIV prevention drug, at a research site in South A
Global DNA synthesis is expanding rapidly, but regulatory frameworks to prevent misuse are struggling to keep pace, leaving the door open for potential bioterrorism threats. The ease with which individuals can order and receive lab-made DNA, as demon
Researchers have made significant progress in a clinical trial of a novel technique that rapidly identifies and isolates the most effective antibodies against infectious diseases, such as COVID-19 and Zika. This breakthrough has the potential to revo
A groundbreaking cure for dengue fever, a mosquito-borne disease that affects over 14 million people annually, has been discovered in the form of a pill called mosnodenvir. This treatment has shown promising results in clinical trials, but its develo
A correction has been made to a 2016 scientific article in Nature, addressing an error in an image related to antimalarial research. The mistake involved a duplicate image in Extended Data Fig. 3c, which has now been replaced with the correct Chloroq
In a groundbreaking effort, the COVAX initiative successfully distributed COVID-19 vaccines worldwide, overcoming monumental logistical hurdles. Led by infectious-disease epidemiologist Seth Berkley, the initiative's radical plan for vaccine equity a
The US is accelerating the rollout of a groundbreaking HIV prevention drug, lenacapavir, which can be administered as a twice-yearly shot, but has excluded South Africa from its initial distribution, despite being a country with one of the highest HI
Researchers have made a significant breakthrough in HIV treatment, reporting that engineered antibodies can help keep the virus under control long-term without constant antiretroviral therapy. In two independent trials, some participants remained hea
Researchers have made significant progress in a clinical trial of a technique that could rapidly provide the body with the most effective antibodies to fight infectious diseases, such as COVID-19 and Zika. This breakthrough involves harnessing the po
A recent report from the National Security Commission on Emerging Biotechnology warns that the US is at risk of losing the biotechnology race to China, citing a narrow window for response. To compete, the US must address a critical issue: restoring t
A groundbreaking clinical trial has yielded promising results for a technique that could rapidly produce the most effective antibodies against a wide range of infectious diseases, including COVID-19 and Zika. This innovative approach leverages the bo
Researchers have made a groundbreaking discovery in the fight against HIV, with two independent trials demonstrating that engineered antibodies can potentially induce a functional cure, allowing some participants to remain healthy without antiretrovi
Get ready for a game-changing breakthrough in infectious disease treatment! Scientists are developing revolutionary antibody therapies that could cure chronic conditions like HIV and reduce the severity of deadly bird flu infections. These synthetic
Researchers have made significant progress in a clinical trial of a technique that could provide a universal solution to infectious diseases by harnessing the power of broadly neutralizing antibodies. These antibodies have the ability to target and i
Researchers have made significant progress in a clinical trial of a novel technique that could rapidly generate highly effective antibodies capable of neutralizing a wide range of infectious diseases, including COVID-19 and Zika. This breakthrough in
Scientists have corrected a 2016 study on antimalarial inhibitors, replacing a duplicate image with the correct one, which showcases the importance of accuracy in medical research. This correction highlights the ongoing efforts to combat malaria, a d
Pioneering research has brought hope to the 40 million people living with HIV, as two independent trials have demonstrated the possibility of a functional cure through engineered antibodies, allowing some participants to remain healthy without antire
The US has expedited the approval of a groundbreaking HIV prevention drug, lenacapavir, which can be administered as a twice-yearly shot, but surprisingly excludes South Africa from its initial rollout, despite the country's dire need for effective H
A recent Indian court ruling has paved the way for Dr. Reddy's Laboratories to manufacture and export generic versions of Novo Nordisk's semaglutide-based diabetes and weight-loss medications, including Ozempic and Wegovy, ahead of their global paten
Share & Engage Share
Share this article